
Actavis hires senior head from PwC
pharmafile | December 24, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Actavis, Jonathon Kellerman, pwC
Jonathon Kellerman has joined Ireland-based speciality pharma firm Actavis as its executive vice president and global chief compliance officer.
Reporting directly to Brent Saunders who is the Dublin firm’s chief executive and president, Kellerman is a member of the Actavis executive leadership team.
Kellerman joins Actavis from PwC where he was a partner in its pharmaceutical and life sciences advisory practice, and takes extensive experience in compliance and sales and marketing performance improvement to the firm.
He has also led major ‘rapid response’ organisational and business process improvement initiatives across business and support functions Actavis adds. Earlier in his career Kellerman worked in healthcare consulting for Zelenkofske Axelrod and in research for Blank Rome.
“Jonathon brings nearly 20 years of experience in helping companies integrate compliance into the value chain and establish a vision for the future of how to effectively manage global risk by focussing on innovative solutions in compliance strategy, operations and process,” says Saunders.
Related Content

Nigerian agency strongly contests that 70% of drugs are fake
Nigeria’s drug regulatory body has fiercely countered claims made by Chief Economist of PwC in …

AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide
New findings of a report by PwC have revealed the biggest spenders in R&D worldwide …

Patently problematic? The impact of the Eli Lilly/Actavis intellectual property battle
The UK Supreme Court has sent shockwaves through the intellectual property world with its recent …






